Yichang Tianrui Biopharm Co., Ltd

Yichang Tianrui Biopharm CO., LTD (HumanwellTianrui Biopharm), was established on November15, 2022, located in Baiyang Bio-industrial Park of Yichang Hi-tech Development Zone in Hubei Province. Our Parent Company is Yichang Humanwell Pharmaceutical Co., Ltd. - a national designated narcotic drug R&D and production enterprise, and a National Key High-Tech Enterprise. The company possesses two Category 1 new drugs and holds over 60% domestic market share in narcotics and psychotropic drugs. With more than 8,000 employees, the company achieved $1.2 billion in sales revenue in 2024.

Humanwell Tianrui Biopharm mainly engage in the comprehensive services of research and development,production, and sales of high value-added APls (including intermediates). With a total investment of $277 million , covering an area of 220,000 square meters, our plant is designed with 13 GMP workshops and constructed in three phases. Phase ll is now operational, with an investment of $112 million, delivering 2 commercial-scale GMP facilities housing 9 production lines. We undertake APl CMO/CDMO business, with a research and development center built according to the highest domestic standards in China. We are aiming to achieve integration and scale in R&D, production, and sales, committed to becoming a word-class service provider of high value-added APl in biopharmaceuticals.